laitimes

Xu Haoyu of Yangtze River Pharmaceutical Group: The pharmaceutical and health industry needs to continue to strengthen its connection with the "digital world".

The "14th Five-Year Plan for the Development of the Digital Economy" mentions that the development of the digital economy is unprecedentedly fast, wide-ranging and influential, and is driving profound changes in the mode of production, lifestyle and governance, and has become a key force in reorganizing global factor resources, reshaping the global economic structure and changing the global competition pattern.

As the core driving force of the new round of industrial revolution, the digital economy is becoming a key engine to promote the high-quality development of the mainland economy. Xu Haoyu, Secretary of the Party Committee, Chairman and President of Yangtze River Pharmaceutical Group, said that at present, Yangtze River Pharmaceutical Group (hereinafter referred to as Yangtze River Pharmaceutical) is accelerating its transformation from "manufacturing" to "intelligent manufacturing", and will continue to strengthen the link with the "digital world", integrate innovation and openness into the pharmaceutical and health industry, develop new quality productivity according to local conditions, and consolidate the development foundation of digital and real integration.

Xu Haoyu of Yangtze River Pharmaceutical Group: The pharmaceutical and health industry needs to continue to strengthen its connection with the "digital world".

Longfengtang palletizing robot. Courtesy of the company

Modern Enterprises Use "Digital Innovation" to Promote "Industrial Renewal"

Industrial modernization is inseparable from digital innovation. Xu Haoyu introduced that over the years, Yangtze River Pharmaceutical has always adhered to the concept of innovation-driven development, and actively implemented the strategy of "simultaneous development of traditional Chinese medicine, chemical medicine, and biological medicine", guided by "digital +", and paid special attention to the use of new Internet technologies and new applications for intelligent transformation and digital transformation and upgrading, so as to improve total factor productivity and core competitiveness of enterprises, and promote the development of industrial digitalization and data assets.

For the production of traditional Chinese medicine, Yangtze River Pharmaceutical implements a traceability system for the whole process of Chinese herbal medicine production through digital and information management, so as to achieve transparency and traceability in every link from planting, production to transportation.

"After the astragalus directly transported from the Dao real estate area is inspected, it will 'enjoy' the fully automatic 'service' of 'washing, moisturizing, cutting and drying' from the time it is sent to the pretreatment workshop. When there is a demand for production, the astragalus that is cut into 1 to 2 cm pieces will be automatically put into the extraction tank along the pre-set route, through intelligent control, and after 3 days of impregnation, infiltration, concentration, alcohol precipitation and other steps to obtain the ointment, ready for pharmaceutical. Jiang Jun, head of digitalization of Yangtze River Pharmaceutical Group Jiangsu Longfengtang Traditional Chinese Medicine Co., Ltd., introduced the digital implementation of modern solutions from pre-processing to extraction of Chinese herbal medicines.

Jiang Jun introduced that the intelligent production line of traditional Chinese medicine extraction of Yangtze River Pharmaceutical Co., Ltd. can accurately control the environmental data required for each step through accurate parameter setting and electronic recording. At the same time, the seamless connection between the various processes of the production line has also increased the production efficiency by 28% and the output by 43%. At the same time, in 2023, Yangtze River Pharmaceutical also successfully passed the acceptance of the "National High-tech Industry Standardization Pilot Project for Intelligent Manufacturing of Traditional Chinese Medicine Process" of the National Standards Committee, creating the first national standardization pilot in the field of intelligent manufacturing of traditional Chinese medicine in Jiangsu Province.

Xu Haoyu of Yangtze River Pharmaceutical Group: The pharmaceutical and health industry needs to continue to strengthen its connection with the "digital world".

Yangtze River Pharmaceutical Intelligent Production Workshop. Courtesy of the company

Digital empowerment, relying on "intellectual living water" to water the "fertile soil of industry"

In the process of internationalization, Yangtze River Pharmaceutical benchmarks against world-class enterprises, continues to introduce high-end R&D and innovative talents with an international vision, actively applies AI and other intelligent application technologies, builds an international R&D platform, attracts more global high-level scientific research talents to join, and continues to reserve superior resources and strength in science and technology, innovation, etc.

Innovation-driven is essentially talent-driven. According to reports, in order to enhance the ability of R&D and innovation, Yangtze River Pharmaceutical attaches great importance to and strengthens the cultivation of high-level and compound talents in talent training, and has cooperated with Peking University, Fudan University, Beijing University of Chinese Medicine, China Pharmaceutical University and other domestic and foreign universities to carry out talent training cooperation related to the pharmaceutical and health industry in terms of integration of industry and education, scientific research and innovation, etc., and jointly promote the organic connection of education chain, talent chain, innovation chain and industrial chain. By strengthening the close connection between the supply side of talent training in colleges and universities and the industrial demand side of enterprises, enterprises can build a stable and reliable talent "reservoir" while providing support for stable employment in the society, so as to continuously reserve professional talents needed for their own development.

Ecological priority, using the "green" content to measure the "gold" content

Yangtze River Pharmaceutical insists on building an environment-friendly enterprise and continuously improves the "green" content of high-quality development of the enterprise. Adhere to cleaner production, and implement the whole process management of source prevention, process control, and end treatment; Through continuous upgrading and transformation of the green manufacturing industry system and strengthening the application of digital technology, the modern development of more than 10 factories distributed across the country is skillfully integrated with the natural ecological environment, and it is full of vitality.

Xu Haoyu of Yangtze River Pharmaceutical Group: The pharmaceutical and health industry needs to continue to strengthen its connection with the "digital world".

A panoramic view of the headquarters of Yangtze River Pharmaceutical Group. Courtesy of the company

At present, through a series of related upgrades and transformations such as digitalization, low-carbonization, intensification, and resource utilization, 6 factories of Yangtze River Pharmaceutical Group have been rated as national green factories, and 3 factories have been rated as national green supply chain management enterprises. Among them, the industrial exhaust emission system of Jiangsu Coastal Pharmaceutical Co., Ltd. has been transformed, and a number of indicators are higher than the national standard; After the third phase of the newly launched photovoltaic clean new energy project is connected to the grid as a whole, it is expected that the overall power generation will reach 815 million kWh during the 25-year service period, reduce carbon emissions by 664,100 tons, and achieve carbon reduction, pollution reduction and green expansion.

"In the future, Yangtze River Pharmaceutical will further increase investment in scientific and technological innovation, focus on quality upgrading, continue to uphold integrity and innovation, accelerate the development of new quality productivity, strive to contribute wisdom and strength to the high-quality development of the pharmaceutical industry and the construction of 'Healthy China', and accelerate the goal of becoming a world-class enterprise." Xu Haoyu said.

Read on